The Sickness-Industrial Complex: How the American Food and Pharmaceutical Ecosystem Profit from Chronic Disease
WASHINGTON — In the modern landscape of public health, a sobering paradox defines the American populace: despite spending more on healthcare and biomedical research than any other nation on Earth, the United States consistently lags behind peer nations in life expectancy, maternal mortality, and rates of chronic illness. To critics, independent researchers, and disgruntled public…
